Oliveira, Mariana A <br/><br/>
Macular atrophy development in neovascular age-related macular degeneration during first year of treatment: Incidence and risk factors.  [electronic resource] 

 -  European journal of ophthalmology  Mar 2021 
 - 521-528 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1724-6016 
<br/><br/><label>Standard No.: </label>10.1177/1120672120908718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Atrophy--diagnostic imaging<br/>Choroidal Neovascularization--drug therapy<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Incidence<br/>Intravitreal Injections<br/>Macula Lutea--diagnostic imaging<br/>Male<br/>Multimodal Imaging<br/>Prospective Studies<br/>Ranibizumab--therapeutic use<br/>Receptors, Vascular Endothelial Growth Factor--therapeutic use<br/>Recombinant Fusion Proteins--therapeutic use<br/>Retrospective Studies<br/>Risk Factors<br/>Tomography, Optical Coherence--methods<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Wet Macular Degeneration--drug therapy